ENTITY
Peijia Medical

Peijia Medical (9996 HK)

82
Analysis
Health Care • China
Peijia Medical is a China-based company specializing in the research, development, and manufacturing of high-end interventional medical devices. It provides comprehensive treatment solutions for structural heart diseases, including transcatheter aortic valve replacement (TAVR) systems, and neurovascular diseases with various neurointerventional devices. The company was founded in 2012 and is headquartered in Suzhou, China.
more
bullish•Peijia Medical
•14 May 2020 13:27

Peijia Medical IPO: Trading Debut Equals First-Day Pop?

Peijia Medical (9996 HK)Ā is a leading transcatheter heart valve medical device company in China. Peijia will commence trading on Friday, 15 May. At...

Logo
444 Views
Share
bullish•Peijia Medical
•14 May 2020 12:16

Peijia Medical (ę²›å˜‰åŒ»ē–—) IPO Trading: Action for the High Flyer

Peijia Medical raised HKD 2.2 billion (USD 283 m) from its global offering and will list on the stock exchange tomorrow. In our previous insight,...

Logo
556 Views
Share
bullish•Kingsoft Cloud
•10 May 2020 13:33

ECM Weekly (10 May 2020) - Kingsoft Cloud, NetEase, Central China New Life, Peijia Medical, Kintor,

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. As...

Share
bullish•Peijia Medical
•05 May 2020 16:08

Peijia Medical IPO: Valuation Insights

Peijia Medical (9996 HK) is a leading transcatheter heart valve medical device company in China. Peijiahas launched a Hong Kong IPO to raise net...

Logo
523 Views
Share
bullish•Peijia Medical
•05 May 2020 11:25

Peijia Medical (ę²›å˜‰åŒ»ē–—) IPO: Hot Deal at Discount

Peijia Medical launched book building to raise up to USD 302 million to list in Hong Kong. It is a leading domestic player in the transcatheter...

Logo
603 Views
Share
x